1 |
SHARARA A I, AWADHI S A, ALHARBI O, et al. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East[J]. Expert Rev Gastroenterol Hepatol,2018,12(9):883-897.
|
2 |
杨 坤, 孟 捷, 高 霞, 等. 姜黄素联合阿托伐他汀对溃疡性结肠炎小鼠的保护作用及机制研究[J]. 世界中医药, 2022, 17(2): 182-186.
|
3 |
朱立伟, 朱达坚. 姜黄素联合美沙拉嗪治疗轻中度溃疡性结肠炎的临床观察[J]. 广东医学, 2019, 40(20): 2921-2924.
|
4 |
林艺娟, 丁 健, 黄循铷, 等. 粪菌移植对小鼠实验性结肠炎TLR4信号通路及肠黏膜屏障的影响[J]. 中国微生态学杂志, 2021, 33(3): 256-263, 270.
|
5 |
翁剑锋, 徐 佳, 刘 朋, 等. 粪菌移植干预治疗溃疡性结肠炎的免疫学机制研究[J]. 中国全科医学, 2022, 25(3): 298-304.
|
6 |
代文洁, 张静阳, 曹平安. 粪菌移植对DSS诱导的实验性结肠炎小鼠影响[J]. 中国保健营养, 2019, 29(1):7-8.
|
7 |
李亚兰, 刘佳静, 马沛广, 等. 葛根芩连汤调控MMP-9/p38 MARK途径修复溃疡性结肠炎小鼠肠黏膜上皮屏障功能[J]. 中国实验方剂学杂志, 2021, 27(4): 8-15.
|
8 |
徐 磊, 沈 雁, 钟继红, 等. 姜黄素对溃疡性结肠炎小鼠Th17细胞分化相关因子表达水平的影响[J]. 中国现代应用药学, 2020, 37(1): 14-18.
|
9 |
DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterol Clin North Am, 2020, 49(4): 643-654.
|
10 |
YAN Y X, SHAO M J, QI Q, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages[J]. Acta Pharmacol Sin, 2018, 39(10): 1633-1644.
|
11 |
夏翩翩,邓飞鸿. YAP蛋白通过激活STAT3调控肠上皮细胞增殖在DSS诱导肠炎及相关肠癌中的作用[J]. 中南大学学报(医学版), 2022,47(12): 1637-1645.
|
12 |
SADEGHI N, MANSOORI A, SHAYESTEH A,et al. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis[J]. Phytother Res, 2020, 34(5):1123-1133.
|
13 |
WANG H Y, GE W, LIU S Q, et al. Curcumin inhibits T follicular helper cell differentiation in mice with dextran sulfate sodium (DSS)-induced colitis[J]. Am J Chin Med, 2022, 50(1): 275-293.
|
14 |
PARAMSOTHY S, NIELSEN S, KAMM M A,et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis[J].Gastroenterology,2019,156(5): 1440-1454.e2.
|
15 |
ZHANG L C, MA X F, LIU P, et al. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis[J]. Exp Biol Med, 2021, 246(13): 1563-1575.
|
16 |
WANG S Y, GUO C, ZHANG T, et al. Tiaochang Xiaoyan extract tablets ameliorate chronic inflammation by activating macrophage lysosomes in chronic colitis rats[J]. Ann Palliat Med, 2021, 10(2): 2203-2216.
|
17 |
XU Y Y, FENG H Y, ZHANG Z Y, et al. The protective role of Scorias spongiosa polysaccharide-based microcapsules on intestinal barrier integrity in DSS-induced colitis in mice[J]. Foods, 2023, 12(3): 669.
|
18 |
JIANG M R, ZHONG G J, ZHU Y C, et al. Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent manner[J]. Acta Biochim Biophys Sin, 2021, 53(9): 1113-1123.
|
19 |
HUANG C L, HUANG Z H, DING L, et al. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis[J]. J Transl Med, 2022, 20(1): 354.
|
20 |
ZHU L, XU L Z, ZHAO S, et al. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis[J]. Appl Microbiol Biotechnol, 2020, 104(12): 5449-5460.
|
21 |
WANG J, ZHANG C L, GUO C M, et al. Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora[J]. Int J Mol Sci, 2019, 20(22): 5751.
|
22 |
REN M T, GU M L, ZHOU X X, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis[J]. World J Gastroenterol, 2019, 25(38): 5800-5813.
|
23 |
KIM K Y, SON J D, HWANG S J, et al. Fermented glutinous rice extract mitigates DSS-induced ulcerative colitis by alleviating intestinal barrier function and improving gut microbiota and inflammation[J]. Antioxidants, 2023, 12(2): 336.
|